Want to make an IMPACT in Alzheimer’s clinical trials? Apply for IMPACT-AD
As we advance scientific knowledge and discovery around treatments and interventions for Alzheimer’s disease and related dementias, our need for experienced professionals to develop and manage clinical trials is greater than ever. If you’re passionate about dementia clinical trials, then the Institute on Methods and Protocols for Advancement of Clinical Trials in ADRD (IMPACT-AD) program may be for you!
Jointly funded by NIA and the Alzheimer’s Association, IMPACT-AD aims to expand and diversify the dementia clinical trials workforce through focused, interactive, and multidisciplinary training. Besides broadening technical and leadership skills, participating in IMPACT-AD can also help cultivate connections with senior trialists and peers. You will also have the opportunity to learn about grant writing and the grants process with federal and non-federal funders.
Apply by April 30 to train in August
The 2023 IMPACT-AD program will be held as an in-person only event in La Jolla, California, the week of Aug. 27-Sept. 1. The deadline to apply is April 30. If your application is accepted by the reviewers, IMPACT-AD will cover your cost of the course and travel expenses.
About IMPACT-AD
Co-led by Joshua Grill, Ph.D. and Rema Raman, Ph.D., IMPACT-AD includes a world-renowned faculty lineup and is designed for qualified investigators with diverse professional and demographic backgrounds. The program offers two tracks:
- Professional (Aug. 27-30): Designed for clinical trial professionals with at least two years of experience in Alzheimer's and related dementias research and/or clinical trials, including but not limited to: clinicians, study coordinators, psychometricians, and other study professionals.
- Fellowship (Aug. 27-Sept. 1): Designed to offer mentored training for participants interested in serving as Principal Investigators in Alzheimer's and related dementias trials; protocol development; and team science approaches in clinical trial design, execution, analysis, and reporting. Applicants should be early-stage faculty or at the fellowship stage of their careers.
An alumni success story
A publication assessing the effectiveness of IMPACT-AD revealed that more than 90% of past trainees agreed IMPACT-AD improved their knowledge of Alzheimer's and related dementias clinical trials. And past program participants have successfully applied the knowledge and relationships built through IMPACT-AD to secure NIA and broader NIH funding. For example, Elizabeth Rhodus, Ph.D. was an occupational therapist from an underrepresented and disadvantaged background who worked with older adults in rural Kentucky. Her drive to improve evidence-based care interventions led her to apply to the first cohort IMPACT-AD fellowship track in 2020.
Leveraging the training and networking experiences she gathered through the program, Rhodus went on to acquire K23 funding through NIA. She’s since completed several clinical trials at the local and national level, including a nationwide project with Alzheimer’s Clinical Trials Consortium sites to better understand clinical trial adaptations during the COVID-19 pandemic.
When asked about her experience as an IMPACT-AD fellow, Rhodus said, “IMPACT-AD propelled my connections and capacity to work in an area that I didn’t think was possible. I am now using these skills to improve dementia care in rural Appalachia and mentor other early career scientists with similar backgrounds to continue to advance the field.”
Apply by April 30!
See what you can do with the experience and connections gained through the IMPACT-AD program. Get tips to enhance your application from this video of our informational webinar. And don’t forget to apply by April 30 for a chance to participate in this year’s program. Leave a comment below or contact IMPACT-AD to learn more!
Add new comment